---
figid: PMC9406846__cimb-44-00245-g002
figtitle: Clinical and Molecular Implications of Osteopontin in Heart Failure
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC9406846
filename: cimb-44-00245-g002.jpg
figlink: /pmc/articles/PMC9406846/figure/cimb-44-00245-f002/
number: F2
caption: Osteopontin signaling in cardiomyocytes. Various factors such as endothelin-1
  (ET-1), norepinephrine (NE), sodium-hydrogen exchanger isoform-1 (NHE-1), reactive
  oxygen species (ROS), dexamethasone (DEX), and aldosterone (Aldo) upregulate osteopontin
  (OPN) in cardiomyocytes. In turn, osteopontin regulates several processes in cardiomyocytes
  via modulating certain signaling pathways. These pathways include induction of hypertrophic
  genes expression via integrin- and CD44-mediated signaling pathways, cardiomyocyte
  hypertrophy and diastolic dysfunction via blocking mitochondrial protein oxoglutarate
  dehydrogenase-like (OGDHL), and cardiomyocyte apoptosis via mitochondrial apoptosis
  signaling pathway, attenuation of the beneficial effects of adrenergic signaling
  by directly binding and blocking G-α subunit of the adrenergic receptors. The overall
  effect of osteopontin signaling in cardiomyocytes results in cardiomyocyte hypertrophy,
  cardiomyocyte apoptosis, and cardiomyocyte mitochondrial dysfunction.
papertitle: Clinical and Molecular Implications of Osteopontin in Heart Failure.
reftext: Argen Mamazhakypov, et al. Curr Issues Mol Biol. 2022 Aug;44(8):3573-3597.
year: '2022'
doi: 10.3390/cimb44080245
journal_title: Current Issues in Molecular Biology
journal_nlm_ta: Curr Issues Mol Biol
publisher_name: MDPI
keywords: osteopontin | right ventricle | left ventricle | heart failure
automl_pathway: 0.9525864
figid_alias: PMC9406846__F2
figtype: Figure
redirect_from: /figures/PMC9406846__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9406846__cimb-44-00245-g002.html
  '@type': Dataset
  description: Osteopontin signaling in cardiomyocytes. Various factors such as endothelin-1
    (ET-1), norepinephrine (NE), sodium-hydrogen exchanger isoform-1 (NHE-1), reactive
    oxygen species (ROS), dexamethasone (DEX), and aldosterone (Aldo) upregulate osteopontin
    (OPN) in cardiomyocytes. In turn, osteopontin regulates several processes in cardiomyocytes
    via modulating certain signaling pathways. These pathways include induction of
    hypertrophic genes expression via integrin- and CD44-mediated signaling pathways,
    cardiomyocyte hypertrophy and diastolic dysfunction via blocking mitochondrial
    protein oxoglutarate dehydrogenase-like (OGDHL), and cardiomyocyte apoptosis via
    mitochondrial apoptosis signaling pathway, attenuation of the beneficial effects
    of adrenergic signaling by directly binding and blocking G-α subunit of the adrenergic
    receptors. The overall effect of osteopontin signaling in cardiomyocytes results
    in cardiomyocyte hypertrophy, cardiomyocyte apoptosis, and cardiomyocyte mitochondrial
    dysfunction.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - tf
  - Ne
  - Nhe1
  - gr
  - mr
  - oo
  - Raf
  - ras
  - Ras64B
  - Ras85D
  - Dsor1
  - rl
  - S6kII
  - NFAT
  - egh
  - LanB1
  - betaTub56D
  - mys
  - Prosbeta1
  - Cyt-c-d
  - Cyt-c-p
  - Decay
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - EDN1
  - TF
  - SPP1
  - SLC9A1
  - ALDOA
  - ALDOB
  - ALDOC
  - CD44
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - KRAS
  - HRAS
  - NRAS
  - MAP2K1
  - MAP2K2
  - MAPK3
  - MAPK1
  - RPS6KA1
  - RPS6KA2
  - RPS6KA3
  - RPS6KA4
  - RPS6KA5
  - RPS6KA6
  - RPS6KB1
  - RPS6KB2
  - NFATC1
  - NFATC2
  - NFATC3
  - NFATC4
  - NFAT5
  - OGDHL
  - B3GNT2
  - B3GNTL1
---
